Absar, Muhammad; Akhtar, Tanveer; Jameel, Abid; Mahmood, Amer; Ullah, Anhar; Aleem, Aamer; Qureshi, Kulsoom; Rehman, Noor; Iqbal, Zafar
(Karachi: Faculty of Pharmacy & Pharmaceutical Sciecnes, University of Karachi, 2020-03-16)
The outcome of chronic myeloid leukemia has been greatly improved by the use of Imatinib (IM), a selective
BCR/ABL kinase inhibitor. The aim of present study was to report long term follow-up & outcome of IM-treated ...